OR51A10P and acute myeloid leukemia: And, ROC curve analysis disclosed that lncRNA ST3GAL6‐AS1 as well as lncRNA OR51A10P could not separate AML patients from controls, while lncRNA DIO3OS, lncRNA MEG3, and lncRNA PR5‐983L19.2 had good values in differentiating AML patients from controls, in which lncRNA DIO3OS had the finest AUC value of 0.828 (95% CI: 0.760‐0.896) (Figure 6D).